SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Gilead's CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Granted Accelerated Approval by the FDA

Benzinga · -